XWE-24960-75865 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-11-18
Dose 1 — Pfizer-BioNTech
Co-administered: Flu
2021-12-09
Registered in v-safe
2021-12-09
Dose 2 — Pfizer-BioNTech
2021-12-09
Health check-in — day 0, dose 2
Feeling: Good · Site: Pain, Swelling · None

Adult check-in
2021-12-10
Health check-in — days 1–6 daily, dose 2
Feeling: Poor · Site: Pain, Itching · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activities

Adult check-in
2021-12-11
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain, Swelling, Itching · Fever · Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to work or attend school

Adult check-in
2021-12-12
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain, Redness, Swelling · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Rash, not including the immediate area around the injection site

Adult check-in
2021-12-13
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain, Redness, Swelling · Rash, not including the immediate area around the injection site

Adult check-in
2021-12-14
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Swelling · Headache, Nausea, Vomiting, Diarrhea · Be unable to work or attend school

Adult check-in
2021-12-16
Health check-in — day 7, dose 2
Feeling: Good · Rash, not including the immediate area around the injection site

Adult check-in
2021-12-23
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-12-30
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2022-01-09
Health check-in — day 28, dose 2
Feeling: Poor

Adult check-in
2022-01-13
Survey response — day 35, dose 2
MedDRA: COVID-19 — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Covid

MedDRA releases: 2024-11 · check-in free text available
2022-01-22
Health check-in — day 42, dose 2
Feeling: Fair

Adult check-in
2022-03-12
Survey response — 3 months, dose 2
MedDRA: No adverse event — Feeling: Good

Free text: None

MedDRA releases: 2024-11 · check-in free text available
2022-12-11
Health check-in — 12 months, dose 2
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-11-18	Pfizer-BioNTech	Flu
2	2021-12-09	Pfizer-BioNTech	No

Free text

Release 10 — day 35, dose 2

2022-01-13

Symptoms: Covid

Release 11 — 3 months, dose 2

2022-03-12

Symptoms: None

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	COVID-19	·	·	✓
SD	No adverse event	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release